Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does UPADACITINIB Cause Aspartate aminotransferase increased? 104 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Aspartate aminotransferase increased have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.

104
Reports of Aspartate aminotransferase increased with UPADACITINIB
0.2%
of all UPADACITINIB reports
1
Deaths
41
Hospitalizations

How Dangerous Is Aspartate aminotransferase increased From UPADACITINIB?

Of the 104 reports, 1 (1.0%) resulted in death, 41 (39.4%) required hospitalization, and 1 (1.0%) were considered life-threatening.

Is Aspartate aminotransferase increased Listed in the Official Label?

Yes, Aspartate aminotransferase increased is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.

What Other Side Effects Does UPADACITINIB Cause?

Pain (4,444) Arthralgia (3,815) Drug ineffective (3,384) Covid-19 (2,978) Rheumatoid arthritis (2,730) Pain in extremity (2,353) Fatigue (2,153) Fall (2,081) Surgery (2,037) Therapy interrupted (1,741)

What Other Drugs Cause Aspartate aminotransferase increased?

METHOTREXATE (1,600) RITUXIMAB (1,351) ADALIMUMAB (1,166) TOCILIZUMAB (975) ETANERCEPT (939) ACETAMINOPHEN (865) LEFLUNOMIDE (863) INFLIXIMAB (823) ABATACEPT (778) NIVOLUMAB (758)

Which UPADACITINIB Alternatives Have Lower Aspartate aminotransferase increased Risk?

UPADACITINIB vs URAPIDIL UPADACITINIB vs UREA UPADACITINIB vs URIDINE TRIACETATE UPADACITINIB vs UROFOLLITROPIN UPADACITINIB vs URSODIOL

Related Pages

UPADACITINIB Full Profile All Aspartate aminotransferase increased Reports All Drugs Causing Aspartate aminotransferase increased UPADACITINIB Demographics